180 Life Sciences Stock Plunges Amid Ethereum's Decline
ByAinvest
Friday, Aug 15, 2025 1:21 am ET1min read
ATNF--
The stock's recent surge can be attributed to the company's Ethereum treasury strategy, which involves accumulating 82,186 ETH valued at approximately $349 million. This strategy aims to become a benchmark for on-chain treasury management among public companies, with a differentiated yield generation program facilitated through a partnership with Electric Capital. The company believes this reserve of ETH will unlock cash flow for shareholders through its on-chain yield generation program.
Ethereum's price has been volatile, with a 3.38% increase to $4,431 over a 24-hour period, marking a 24% increase from the previous week. The company's treasury strategy is part of its broader evolution from a biotechnology company to a software-enabled gaming and entertainment enterprise.
Despite the recent gains, the stock's after-hours decline reflects the broader market's reaction to Ethereum's price drop. The company's stock has seen a year-to-date increase of 83.52% and a 91.95% rise over the past 12 months. The recent announcement has led to heavy trading, with approximately 33 million shares changing hands today compared to a three-month average of about 4.78 million units.
References:
[1] https://finance.yahoo.com/news/180-life-sciences-ethzilla-holds-120000891.html
[2] https://www.ainvest.com/news/ethereum-surges-4-400-180-life-sciences-stock-rises-132-rebranding-ethzilla-corporation-2508/
ETH--
180 Life Sciences Corp. shares slid 1.45% in after-hours trading, coinciding with the decline of Ethereum. The biotechnology company's stock has surged 116% in a week and 755% in a month, aligning with ETH's rise. The firm holds 82,186 ETH, valued at over $381 million, and plans to rebrand as ETHZilla Corporation. Billionaire venture capitalist Peter Thiel holds a 7.5% stake in the firm.
180 Life Sciences Corp. (ATNF) shares slid 1.45% in after-hours trading, coinciding with the decline of Ethereum. The biotechnology company's stock has surged 116% in a week and 755% in a month, aligning with ETH's rise. The firm holds 82,186 ETH, valued at over $381 million, and plans to rebrand as ETHZilla Corporation. Billionaire venture capitalist Peter Thiel holds a 7.5% stake in the firm.The stock's recent surge can be attributed to the company's Ethereum treasury strategy, which involves accumulating 82,186 ETH valued at approximately $349 million. This strategy aims to become a benchmark for on-chain treasury management among public companies, with a differentiated yield generation program facilitated through a partnership with Electric Capital. The company believes this reserve of ETH will unlock cash flow for shareholders through its on-chain yield generation program.
Ethereum's price has been volatile, with a 3.38% increase to $4,431 over a 24-hour period, marking a 24% increase from the previous week. The company's treasury strategy is part of its broader evolution from a biotechnology company to a software-enabled gaming and entertainment enterprise.
Despite the recent gains, the stock's after-hours decline reflects the broader market's reaction to Ethereum's price drop. The company's stock has seen a year-to-date increase of 83.52% and a 91.95% rise over the past 12 months. The recent announcement has led to heavy trading, with approximately 33 million shares changing hands today compared to a three-month average of about 4.78 million units.
References:
[1] https://finance.yahoo.com/news/180-life-sciences-ethzilla-holds-120000891.html
[2] https://www.ainvest.com/news/ethereum-surges-4-400-180-life-sciences-stock-rises-132-rebranding-ethzilla-corporation-2508/

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet